The present stock price for Bristol-Myers Squibb Co. (BMY) is $48.90. In the last trading session, the stock made a considerable jump, reaching $50.17 after an opening price of $48.78. The stock briefly fell to $48.42 before ending the session at $50.84.
Bristol-Myers Squibb Co.’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $81.43 on 12/01/22 and a low of $49.49 for the same time frame on 11/20/23.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
52-week price history of BMY Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Bristol-Myers Squibb Co.’s current trading price is -39.95% away from its 52-week high, while its distance from the 52-week low is -1.19%. The stock’s price range during the 52-week period has remained between $49.49 and $81.43. In the Healthcare sector, the company’s shares saw a trading volume of around 27.94 million for the day, which was evidently higher than the average daily volume of 12.05 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Bristol-Myers Squibb Co. (BMY) has experienced a quarterly decline of -20.95% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 99.50B and boasts a workforce of 34300 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 58.68, with a change in price of -15.10. Similarly, Bristol-Myers Squibb Co. recorded 11,713,865 in trading volume during the last 100 days, posting a change of -23.59%.
Examining BMY’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for BMY stands at 1.35. Similarly, the long-term debt-to-equity ratio is also 1.16.
BMY Stock Stochastic Average
Bristol-Myers Squibb Co.’s raw stochastic average for the past 50 days is presently 3.81%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 5.75%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 14.02% and 18.18%, respectively.
BMY Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price loss of -32.04% this year. Over the last six months, there has been a stronger performance of -25.70%. The price of BMY leaped by -13.39% during the last 30 days period. For the last 5-days stocks have slided -2.49%.
